Abstract
Primary and secondary malignant hepatic tumors are a major health problem worldwide. While metastases are common in western countries, primary liver cancers are frequently diagnosed in Asia and Africa. However, recent data suggest that the incidence and mortality of hepatocellular carcinoma (HCC) in Western nations are on the rise (Taylor- Robinson et al. 1997; Llovet et al. 2003). Likewise, the liver is the most common site for metastases. In 25%–50% of patients with malignancies liver metastases were observed at autopsy (Bernardino et al. 1982). The most frequent primary sites are colon, breast, pancreas, and lung. In the case of colorectal metastatic disease, the liver is the only metastatic site in 20%–30% of patients (Sasson and Sigurdson 2002).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramson R, Rosen M, Perry L, Brophy D, Raeburn S, Stuart K (2000) Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 216:485–491
Agarwala SS, Panikkar R, Kirkwood JM (2004) Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 14:217–222
Allgaier HP, Deibert P, Olschewski M, Spamer C, Blum U, Gerok W, Blum HE (1998) Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection-a single-center analysis including 132 patients. Int J Cancer 79:601–605
Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE (1999) Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 353:1676–1677
Allison DJ, Booth A (1990) Arterial embolization in the management of liver metastases. Cardiovasc Intervent Radiol 13:161–168
Bernardino ME, Thomas JL, Barnes PA, Lewis E (1982) Diagnostic approaches to liver and spleen metastases. Radiol Clin North Am 20:469–485
Bianco S, Merkel C, Savastano S et al (1996) Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma. Gut 39:325–329
Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A (1992) Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387–394
Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969–985
Bruix J, Sala M, Llovet J (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127:S179–188
Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16:353–361
Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54
Castells A, Bruix J, Ayuso C, Bru C, Montanya X, Boix L, Rodes J (1995) Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol 22:410–415
Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F (2000) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 215:123–128
Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8:74–78
Choi BI, Kim HC, Han JK, Park JH, Kim YI, Kim ST, Lee HS, Kim CY, Han MC (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182:709–713
Chung JW, Park JH, Im JG, Han JK, Han MC (1993) Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187:689–693
Cioni D, Lencioni R, Bartolozzi C (2000) Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 10:1570–1575
Colella G, Bottelli R, De Carlis L et al (1998) Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 11:S193–196
Daniels JR, Sternlicht M, Daniels AM (1988) Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney. Cancer Res 48:2446–2450
Diamandidou E, Ajani JA, Yang DJ, Chuang VP, Brown CA, Carrasco HC, Lawrence DD, Wallace S (1998) Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol 170:339–344
Dominguez S, Denys A, Madeira I, Hammel P, Vilgrain V, Menu Y, Bernades P, Ruszniewski P (2000) Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol 12:151–157
Falconi M, Bassi C, Bonora A, Sartori N, Procacci C, Talamini G, Mansueto GC, Pederzoli P (1999) Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours. Dig Surg 16:32–38
Feun LG, Reddy KR, Yrizarry JM et al (1994) A phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 17:405–410
Fiorentini G, Poddie DB, Giorgi UD et al (2000) Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 17:163–173
Fiorentini G, Rossi S, Bonechi F, Vaira M, De Simone M, Dentico P, Bernardeschi P, Cantore M, Guadagni S (2004) Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study. J Chemother 16:293–297
Gates J, Hartnell GG, Stuart KE, Clouse ME (1999) Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 19:399–414
Gattoni F, Dova S, Uslenghi CM (2000) Three-year followup of 62 cirrhotic patients with hepatocellular carcinoma treated with chemoembolization. Minerva Chir 55:31–37
Gupta S, Johnson MM, Murthy R et al (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 104:1590–1602
Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M (1988) Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma. Am J Gastroenterol 83:837–840
Hosoki T, Yosioka Y, Matsubara T, Minamitani K, Higashi M, Ohtani M, Choi S, Mitomo M, Tono T (1999) Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Assessment of the therapeutic effect. Acta Radiol 40:639–643
Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?. Rofo 176:375–385
Ichikawa T, Yamada T, Takagi H, Abe T, Ito H, Sakurai S, Nagamine T, Mori M (1997) Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma. J Gastroenterol 32:405–409
Inoue H, Kobayashi H, Itoh Y, Shinohara S (1989) Treatment of liver metastases by arterial injection of adriamycin/mitomycin C lipiodol suspension. Acta Radiol 30:603–608
Jaeger HJ, Mehring UM, Castaneda F, Hasse F, Blumhardt G, Loehlein D, Mathias KD (1996) Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19:388–396
Kameyama M, Imaoka S, Fukuda I, Nakamori S, Sasaki Y, Fujita M, Hasegawa Y, Iwanaga T (1992) Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer. Surgery 114:97–101
Kato T, Nemoto R, Mori H, Takahashi M, Tamakawa Y, Harada M (1981) Arterial chemoembolization with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects. J Am Med Assocama 245:1123–1127
Kennedy KA, Rockwell S, Sartorelli AC (1980) Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40:2356–2360
Kobayashi H, Inoue H, Shimada J, Yano T, Maeda T, Oyama T, Shinohara S (1987) Intra-arterial injection of adriamycin/mitomycin C lipiodol suspension in liver metastases. Acta Radiol 28:275–280
Kress O, Wagner HJ, Wied M et al (2003) Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors — a retrospective single-center analysis. Digestion 68:94–101
Kuroda C, Iwasaki M, Tanaka T, Tokunaga K, Hori S, Yoshioka H, Nakamura H, Sakurai M, Okamura J (1983) Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study. Radiology 149:85–89
Lang EK, Brown CL Jr (1993) Colorectal metastases to the liver: selective chemoembolization. Radiology 189:417–422
Lee K, Sung K, Lee D, Park S, Kim K, Yu J (2002) Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 22:1077–1091
Li XP, Meng ZQ, Guo WJ, Li J (2005) Treatment for liver metastases from breast cancer: results and prognostic factors. World J Gastroenterol 11:3782–3787
Livraghi T (2003) Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 10:67–76
Lladò L, Virgili J, Figueras J et al (2000) A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 88:50–57
Llovet J, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442
Llovet J, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171
Makuuchi M, Sukigara M, Mori T, Kobayashi J, Yamazaki S, Hasegawa H, Moriyama N, Takayasu K, Hirohashi S (1985) Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156:331–334
Martinelli DJ, Wadler S, Bakal CW, Cynamon J, Rozenblit A, Haynes H, Kaleya R, Wiernik PH (1994) Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma [see comments]. Cancer 74:1706–1712
Mavligit GM, Charnsangavej C, Carrasco CH, Patt YZ, Benjamin RS, Wallace S (1988) Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. J Am Med Assoca 260:974–976
Meakem TJd, Unger EC, Pond GD, Modiano MR, Alberts DR (1992) CT findings after hepatic chemoembolization. J Comput Assist Tomogr 16:916–920
Midorikawa T, Kumada K, Kikuchi H et al (2000) Microwave coagulation therapy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 7:252–259
Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Ideo G (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19:1115–1123
Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C (2003) Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first-and second-line treatment of disseminated colorectal liver metastases. Hepatogastroenterology 50:1919–1926
Pan SS, Andrews PA, Glover CJ, Bachur NR (1984) Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 259:959–966
Park JH, Han JK, Chung JW, Han MC, Kim ST (1993) Postoperative recurrence of hepatocellular carcinoma: results of transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 16:21–24
Patel K, Sullivan K, Berd D, Mastrangelo MJ, Shields CL, Shields JA, Sato T (2005) Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 15:297–304
Patt YZ, Chuang VP, Wallace S, Hersh EM, Freireich EJ, Mavligit GM (1981) The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet 1:349–350
Pelletier G, Ducreux M, Gay F et al (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 29:129–134
Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P (1993) Hepatic chemoembolization: safety with portal vein thrombosis. J Vasc Interv Radiol 4:347–351
Popov I, Lavrnic S, Jelic S, Jezdic S, Jasovic A (2002) Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit. Neoplasma 49:43–48
Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF (2002) Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13:S211–221
Raoul JL, Heresbach D, Bretagne JF, Ferrer DB, Duvauferrier R, Bourguet P, Messner M, Gosselin M (1992) Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 70:585–590
Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, Ducreux M (2003) Transcatheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13:136–140
Sakamoto I, Aso N, Nagaoki K et al (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18:605–619
Sakamoto Y, Kita Y, Takayama T, Kawauchi N, Minagawa M, Makuuchi M (1999) Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case. Hepatogastroenterology 46:453–456
Sakamoto I, Iwanaga S, Nagaoki K et al (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181:79–87
Salman HS, Cynamon J, Jagust M, Bakal C, Rozenblit A, Kaleya R, Negassa A, Wadler S (2002) Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2:173–179
Samejima M, Tamura S, Kodama T, Yuuki Y, Takasaki J, Sekiva R, Koga Y, Watanabe K (1990) Pulmonary complication following intra-arterial infusion of lipiodol-adriamycin emulsion for hepatocellular carcinoma, report of a case. Nippon Igaku Hoshasen Gakkai Zasshi 50:24–28
Sasson AR, Sigurdson ER (2002) Surgical treatment of liver metastases. Semin Oncol 29:107–118
Savastano S, Miotto D, Casarrubea G, Teso S, Chiesura-Corona M, Feltrin GP (1999) Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child’s grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 28:334–340
Soulen MC (1994) Chemoembolization of hepatic malignancies. Oncology (Huntingt) 8:77–84; discussion 84, 89–90 passim
Starkhammar H, Hakansson L, Morales O, Svedberg J (1987) Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres. Acta Oncol 26:295–300
Steger W, Vogl TJ, Hosten N, Steger S, Hidajat N, Felix R (1998) Doppler sonographic monitoring control of perfusion of hepatocellular carcinoma after arterial chemoembolization. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 168:49–56
Stuart K, Stokes K, Jenkins R, Trey C, Clouse M (1993) Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer 72:3202–3209
Sumie S, Yamashita F, Ando E, Tanaka M, Yano Y, Fukumori K, Sata M (2003) Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. AJR Am J Roentgenol 181:1327–1334
Tajima T, Honda H, Kuroiwa T, Yabuuchi H, Okafuji T, Yosimitsu K, Irie H, Aibe H, Masuda K (2002) Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol 13:893–900
Takayasu K, Moriyama N, Muramatsu Y, Shima Y, Ushio K, Yamada T, Kishi K, Hasegawa H (1985) Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol 144:135–138
Taniguchi H, Takahashi T, Yamaguchi T, Sawai K (1989) Intraarterial infusion chemotherapy for metastatic liver tumors using multiple anti-cancer agents suspended in a lipid contrast medium. Cancer 64:2001–2006
Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC (1997) Increase in primary liver cancer in the UK, 1979–94. Lancet 350:1142–1143
Tellez C, Benson AB 3rd, Lyster MT, Talamonti M, Shaw J, Braun MA, Nemcek AA Jr, Vogelzang RL (1998) Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250–1259
Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M, Lasser P, Elias D, Rougier P (1993) Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189:541–547
Tsushima Y, Unno Y, Koizumi J, Kusano S (1998) Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT). Dig Dis Sci 43:317–322
Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M (2000) Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 88:1574–1581
Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214:349–357
Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG (2002) Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology 225:367–377
Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangos S (2003) Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 229:457–464
Vogl TJ, Wetter A, Lindemayr S, Zangos S (2005) Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 234:917–922
Wallace S, Carrasco CH, Charnsangavej C, Richli WR, Wright K, Gianturco C (1990) Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiology 13:153–160
Wang LQ, Persson BG, Bergqvist L, Bengmark S (1994) Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein. Cancer 74:2454–2459
Wasser K, Giebel F, Fischbach R, Tesch H, Landwehr P (2005) Transarterial chemoembolization of liver metastases of colorectal carcinoma using absorbable starch microspheres (Spherex). Our own investigations and review of the literature. Radiologe 45:633–643
Wollner IS, Walker-Andrews SC, Smith JE, Ensminger W (1986) Phase II study of hepatic arterial degradable starch microspheres and mitomycin. Cancer Drug Deliv 3:279–284
Yamashita Y, Takahashi M, Bussaka H, Fukushima S, Kawaguchi T, Nakano M (1989) Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report. Cancer 64:2437–2444
You YT, Changchien CR, Huang JS, Ng KK (2005) Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis 21(1):33–37
Zangos S, Mack MG, Straub R, Engelmann K, Eichler K, Balzer J, Vogl TJ (2001) Transarterial chemoembolization (TACE) of liver metastases. A palliative therapeutic approach. Radiologe 41:84–90
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zangos, S., Eichler, K., Vogl, T.J. (2008). Transarterial Chemoembolization (TACE) in Primary and Secondary Liver Tumors. In: Vogl, T.J., Helmberger, T.K., Mack, M.G., Reiser, M.F. (eds) Percutaneous Tumor Ablation in Medical Radiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68250-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-68250-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22518-8
Online ISBN: 978-3-540-68250-9
eBook Packages: MedicineMedicine (R0)